2005•Journal of Clinical UrologyRequires access

The effects comparison of FK506 and CsA on serum lipids in renal allograft recipients

Xiaofei Hou

Open publisher page 0 citations

Abstract

Objective:Objectives: To compare the effects between tacrolimus (FK506) and cyclosporin(CsA) on serum lipids after renal transplantation.Methods:There were 209 renal recipients involved in this study, among which 116 on CsA treatment and 93 on tacrolimus treatment. Main follow-up time was three month, six month and one year after operation. Chi-square test was used during statistical analysis.Results:No significant difference of the serum lipids mean levels was found between two groups before operation. The percentage of patients with hyperlipidemia in CsA group was significantly higher than that in FK506 group in the three-month, six-month and one-year follow-up. Moreover, there are staring difference among various time in CsA group.Conclusions:FK506 may be superior to CsA with respect to its effect on serum lipids.

About this research paper

What this paper is about

Objective:Objectives: To compare the effects between tacrolimus (FK506) and cyclosporin(CsA) on serum lipids after renal transplantation.Methods:There were 209 renal recipients involved in this study, among which 116 on CsA treatment and 93 on tacrolimus treatment. Main follow-up time was three month, six month and one year after operation. Chi-square test was used during statistical analysis.Results:No significant difference of the serum lipids mean levels was found between two groups before operation. The percentage of patients with hyperlipidemia in CsA group was significantly higher than that in FK506 group in the three-month, six-month and one-year follow-up. Moreover, there are staring difference among various time in CsA group.Conclusions:FK506 may be superior to CsA with respect to its effect on serum lipids.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:Objectives: To compare the effects between tacrolimus (FK506) and cyclosporin(CsA) on serum lipids after renal transplantation.Methods:There were 209 renal recipients involved in this study, among which 116 on CsA treatment and 93 on tacrolimus treatment. Main follow-up time was three month, six month and one year after operation. Chi-square test was used during statistical analysis.Results:No significant difference of the serum lipids mean levels was found between two groups before operation. The percentage of patients with hyperlipidemia in CsA group was significantly higher than that in FK506 group in the three-month, six-month and one-year follow-up. Moreover, there are staring difference among various time in CsA group.Conclusions:FK506 may be superior to CsA with respect to its effect on serum lipids.

Key concepts: Medicine, Hyperlipidemia, Tacrolimus, Blood lipids, Urology, Significant difference, Transplantation, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
The effects comparison of FK506 and CsA on serum lipids in renal allograft recipients — Research Paper | ScholarLens